The identified panel of three microRNA biomarkers can potentially be used as a diagnostic tool for early stage pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Ganepola AP Ganepola (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: